Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -287.84% is 15% above its 5-year average of -337.11%, around the middle of its 5-year range (-736.94%–24.89%).
12.95% above its 12-month average of -330.67%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -400.97%.
NET PROFIT MARGIN
-287.84%
NET PROFIT MARGIN AVG TTM
-330.67%
NET PROFIT MARGIN AVG 3Y
-252.07%
NET PROFIT MARGIN AVG 5Y
-337.11%
NET PROFIT MARGIN AVG 10Y
-293.21%
NET PROFIT MARGIN AVG 15Y
-235.70%
NET PROFIT MARGIN AVG 20Y
-199.48%
CURRENT VS TTM AVG
+12.95%
CURRENT VS 3Y AVG
-14.19%
CURRENT VS 5Y AVG
+14.62%
CURRENT VS 10Y AVG
+1.83%
CURRENT VS 15Y AVG
-22.12%
CURRENT VS 20Y AVG
-44.30%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-110607.69%
vs the sector median at left
Nektar Therapeutics
Market Cap
$1.15B
Net Profit Margin
-287.84%
TTM Avg
-330.67%
3Y Avg
-252.07%
5Y Avg
-337.11%
Market Cap
$1.14B
Net Profit Margin
2.07%
TTM Avg
2.94%
3Y Avg
0.11%
5Y Avg
-9.38%
Market Cap
$1.14B
Net Profit Margin
10.76%
TTM Avg
17.71%
3Y Avg
18.77%
5Y Avg
14.94%
Market Cap
$1.14B
Net Profit Margin
-13.51%
TTM Avg
-5.33%
3Y Avg
-11.32%
5Y Avg
-12.84%
Market Cap
$1.13B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.17B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.12B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.12B
Net Profit Margin
-6.08%
TTM Avg
-15.19%
3Y Avg
-17.99%
5Y Avg
-12.77%
Market Cap
$1.11B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nektar Therapeutics (NKTR) | $1.15B | -287.84% | -330.67% | -252.07% | -337.11% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.14B | 2.07% | 2.94% | 0.11% | -9.38% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 10.76% | 17.71% | 18.77% | 14.94% |
| Harrow Health, Inc. (HROW)vs › | $1.14B | -13.51% | -5.33% | -11.32% | -12.84% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | 0.00% | 0.00% | 0.00% | 0.00% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | 0.00% | 0.00% | 0.00% | 0.00% |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.12B | 0.00% | 0.00% | 0.00% | 0.00% |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.12B | -6.08% | -15.19% | -17.99% | -12.77% |
| Replimune Group, Inc. (REPL)vs › | $1.11B | 0.00% | 0.00% | 0.00% | 0.00% |
| OPKO Health, Inc. (OPK)vs › | $1.10B | -12.40% | -22.32% | -24.80% | -16.46% |
Operating Margin
-240.4%
Net Profit Margin
-287.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -400.97% |
| 2026-03-31 | -413.44% |
| 2025-12-31 | -165.45% |
| 2025-09-30 | -301.29% |
| 2025-06-30 | -372.20% |
| 2025-03-31 | -486.44% |
| 2024-12-31 | 24.89% |
| 2024-09-30 | -153.61% |
| 2024-06-30 | -222.93% |
| 2024-03-31 | -170.07% |
| 2023-12-31 | -176.17% |
| 2023-09-30 | -189.85% |
| 2023-06-30 | -249.39% |
| 2023-03-31 | -634.52% |
| 2022-12-31 | -271.03% |
| 2022-09-30 | -249.94% |
| 2022-06-30 | -736.94% |
| 2022-03-31 | -364.16% |
| 2021-12-31 | -582.37% |
| 2021-09-30 | -520.47% |
| 2021-06-30 | -443.06% |
| 2021-03-31 | -520.01% |
| 2020-12-31 | -499.54% |
| 2020-09-30 | -361.56% |
| 2020-06-30 | -163.78% |
| 2020-03-31 | -274.16% |
| 2019-12-31 | -331.24% |
| 2019-09-30 | -338.18% |
| 2019-06-30 | -471.41% |
| 2019-03-31 | -419.93% |
| 2018-12-31 | -246.60% |
| 2018-09-30 | -346.31% |
| 2018-06-30 | 89.31% |
| 2018-03-31 | -251.96% |
| 2017-12-31 | -35.43% |
| 2017-09-30 | 39.80% |
| 2017-06-30 | -173.09% |
| 2017-03-31 | -258.27% |
| 2016-12-31 | -112.67% |
| 2016-09-30 | -118.96% |
| 2016-06-30 | -148.32% |
| 2016-03-31 | -33.11% |
| 2015-12-31 | -137.51% |
| 2015-09-30 | -13.68% |
| 2015-06-30 | -232.37% |
| 2015-03-31 | 31.08% |
| 2014-12-31 | -233.66% |
| 2014-09-30 | 53.14% |
| 2014-06-30 | -114.46% |
| 2014-03-31 | -233.68% |
| 2013-12-31 | -153.02% |
| 2013-09-30 | -27.16% |
| 2013-06-30 | -126.24% |
| 2013-03-31 | -239.36% |
| 2012-12-31 | -250.29% |
| 2012-09-30 | -236.51% |
| 2012-06-30 | -144.76% |
| 2012-03-31 | -228.97% |
| 2011-12-31 | -237.58% |
| 2011-09-30 | -88.92% |
| 2011-06-30 | -209.92% |
| 2011-03-31 | -318.91% |
| 2010-12-31 | -49.83% |
| 2010-09-30 | -22.97% |
| 2010-06-30 | -1.21% |
| 2010-03-31 | -18.44% |
| 2009-12-31 | -19.68% |
| 2009-09-30 | -302.91% |
| 2009-06-30 | -246.91% |
| 2009-03-31 | -327.54% |
| 2008-12-31 | 270.81% |
| 2008-09-30 | -172.76% |
| 2008-06-30 | -163.59% |
| 2008-03-31 | -203.61% |
| 2007-12-31 | 59.36% |
| 2007-09-30 | -33.06% |
| 2007-06-30 | -41.73% |
| 2007-03-31 | -30.20% |
| 2006-12-31 | -55.58% |
| 2006-09-30 | -33.44% |
| 2006-06-30 | -104.33% |
| 2006-03-31 | -115.58% |
| 2005-12-31 | -329.18% |
| 2005-09-30 | -65.45% |
| 2005-06-30 | -94.26% |
| 2005-03-31 | -91.83% |
| 2004-12-31 | -61.44% |
| 2004-09-30 | -71.65% |
| 2004-06-30 | -77.69% |
| 2004-03-31 | -154.85% |
| 2003-12-31 | 13.71% |
| 2003-09-30 | -62.89% |
| 2003-06-30 | -46.99% |
| 2003-03-31 | -78.15% |
| 2002-12-31 | -137.31% |
| 2002-09-30 | -114.23% |
